Bone Biologics entered into an exclusive license agreement with UCLA for global application of NELL-1 protein in the treatment of osteoporosis and trauma, through a technology transfer.Â
DePuy Synthes entered into an exclusive U.S. agreement with JointPoint to co-market a surgical navigation platform for total hip replacement, beginning in 2H17.
Life Spine announced the first cases performed using multiple methods of in situ expansion with the PROLIFT® Lordotic system and the TiBOW™ Expandable TLIF Spacer.